Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: A randomized, controlled trial

Pediatrics

Volumn 123, Issue 1, 2009, Pages 137-142

  Rojas, Mario Augusto ^a   Lozano, Juan Manuel ^b   Rojas, Maria Ximena ^b   Laughon, Matthew ^c   Bose, Carl Lewis ^c   Rondon, Martin Alonso ^b   Charry, Laura ^b   Bastidas, Jaime Alberto ^d   Perez, Luis Alfonso ^e   Rojas, Catherine ^f   Ovalle, Oscar ^g   Celis, Luz Astrid ^h   Garcia Harker, Jorge ⁱ   Jaramillo, Martha Lucia ^j  

^a VANDERBILT UNIVERSITY   (United States)

^b PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d Clinica Los Farallones/Remedios   (Colombia)

^e Universidad Industrial de Santander   (Colombia)

^f Policlinico del Olaya   (Colombia)

^g SaludCoop   (Colombia)

^h Hospital Universitario Simón Bolivar   (Colombia)

ⁱ Clínica Materno Infantil San Luis   (Colombia)

^j Fundacion Valle de LiLi   (Colombia)

more..

Author keywords

Early nasal continuous positive airway pressure; Mandatory ventilation; Preterm infant; Respiratory distress syndrome; Very early surfactant

Indexed keywords

AMINOPHYLLINE; BERACTANT; LUNG SURFACTANT; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY ROOM; EXTUBATION; FEMALE; GESTATION PERIOD; HUMAN; INFANT; INFANT MORTALITY; INTUBATION; LEUKOMALACIA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; TREATMENT OUTCOME; COMPARATIVE STUDY; LUNG DISEASE; METHODOLOGY; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LUNG DISEASES; MALE; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; SURFACE-ACTIVE AGENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 59449100867     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-3501     Document Type: Article

References (25)

1. Parker RA, Lindstrom DP, Cotton RB. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics. 1992;90(5):663-668
2. Bancalari E, del Moral T. Bronchopulmonary dysplasia and surfactant. Biol Neonate. 2001;80(suppl 1):7-13
3. Bruce MC, Schuyler M, Martin RJ, Starcher BC, Tomashefski JF Jr, Werdig KE. Risk factors for the degradation of lung elastic fibers in the ventilated neonate: implications for impaired lung development in bronchopulmonary dysplasia. Am Rev Respir Dis. 1992;146(1):204-212
4. Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics. 1987;79(1):26-30
5. Van Marter LJ, Allred EN, Pagano M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics. 2000;105(6): 1194-1201
6. Manktelow BN, Draper ES, Annamalai S, Field D. Factors affecting the incidence of chronic lung disease of prematurity in 1987, 1992, and 1997. Arch Dis Child Fetal Neonatal Ed. 2001;85(1):F33-F35
7. Korhonen P, Tammela O, Koivisto AM, Laippala P, Ikonen S. Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants. Early Hum Dev. 1999; 54(3):245-258
8. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev. 1998;53(1):81-94
9. Hernandez LA, Peevy KJ, Moise AA, Parker JC. Chest wall restriction limits high airway pressure-induced lung injury in young rabbits. J Appl Physiol. 1989;66(5):2364-2368
10. Parker JC, Hernandez La, Peevy KJ. Mechanisms of ventilatori nduced lung injury. Crit Care Med. 1993;21(1):131-143
11. Björklund LJ, Ingimarsson J, Curstedt T, et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res. 1997;42(3):348-355
12. Van Marter LJ, Pagano M, Allred EN, Leviton A, Kuban KC. Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J Pediatr. 1992;120(6):938-946
13. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants [Cochrane review]. In: The Cochrane Library. Issue 2. Oxford, United Kingdom: Update Software; 2001
14. Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med. 1994;331(16): 1051-1055
15. Verder H, Albertsen P, Ebbeson F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics. 1999;103(2). Available at: www. pediatrics.org/cgi/content/full/103/2/e24
16. Reininger A, Khalak R, Kendig JW, et al. Surfactant administration by transient intubation in infants 29 to 25 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized control trial. J Perinatol. 2005;25(11):703-708
17. American Academy of Pediatrics, Committee on Fetus and Newborn. Levels of neonatal care [published correction appears in Pediatrics. 2005;115(4):1118]. Pediatrics. 2004;114(5): 1341-1347
18. Kattwinkel J, ed. Textbook of Neonatal Resuscitation. 4th ed. Elk Grove Village, IL: American Academy of Pediatrics and American Heart Association; 2000
19. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight less than 1500 grams. J Pediatr. 1978;92(4):529-534
20. BowermanRA, Donn SM, DiPietro MA, D'Amato CJ, Hicks SP. Periventricular leukomalacia in the pre-term newborn infant: sonographic and clinical features. Radiology. 1984;151(2): 383-388
21. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics. 2004; 113(6). Available at: www.pediatrics.org/ cgi/content/full/113/6/e560
22. Gerhardt T, McCarthy J, Bancalari E. Effect of aminophylline on respiratory center activity and metabolic rate in premature infants with idiopathic apnea. Pediatrics. 1979;63(4):537-542
23. Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev. 2002;(4):CD000501
24. Soll RF. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2000;(2):CD000141
25. Lozano JM, Duque OR, Buitrago T, Behaine S. Pulse oximetry reference values at high altitude. Arch Dis Child. 1992;67(3): 299 -301